| Literature DB >> 29502462 |
Ana Esteve-Solé1,2, Ithaisa Sologuren3, María Teresa Martínez-Saavedra3, Àngela Deyà-Martínez1,2, Carmen Oleaga-Quintas4,5, Rubén Martinez-Barricarte6, Andrea Martin-Nalda7, Manel Juan1,2,8, Jean-Laurent Casanova4,5,6,9,10, Carlos Rodriguez-Gallego3, Laia Alsina1,2, Jacinta Bustamante4,5,6,11.
Abstract
The integrity of the interferon (IFN)-γ circuit is necessary to mount an effective immune response to intra-macrophagic pathogens, especially Mycobacteria. Inherited monogenic defects in this circuit that disrupt the production of, or response to, IFN-γ underlie a primary immunodeficiency known as Mendelian susceptibility to mycobacterial disease (MSMD). Otherwise healthy patients display a selective susceptibility to clinical disease caused by poorly virulent mycobacteria such as BCG (bacille Calmette-Guérin) vaccines and environmental mycobacteria, and more rarely by other intra-macrophagic pathogens, particularly Salmonella and M. tuberculosis. There is high genetic and allelic heterogeneity, with 19 genetic etiologies due to mutations in 10 genes that account for only about half of the patients reported. An efficient laboratory diagnostic approach to suspected MSMD patients is important, because it enables the establishment of specific therapeutic measures that will improve the patient's prognosis and quality of life. Moreover, it is essential to offer genetic counseling to affected families. Herein, we review the various genetic and immunological diagnostic approaches that can be used in concert to reach a molecular and cellular diagnosis in patients with MSMD.Entities:
Keywords: MSMD; Mycobacteria; diagnosis; interferon gamma; intracellular pathogens; primary immunodeficiency
Mesh:
Substances:
Year: 2018 PMID: 29502462 PMCID: PMC5880527 DOI: 10.1080/10408363.2018.1444580
Source DB: PubMed Journal: Crit Rev Clin Lab Sci ISSN: 1040-8363 Impact factor: 6.250